(Q40341498)

19 September 2017

title

Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes (English)

1 reference

19 September 2017

0 references

1 reference

3

Martina Beltramello

1 reference

19 September 2017

8

Michael S Diamond

0 references

Federica Sallusto

11

object named as

Federica Sallusto

0 references

Jacob Schlesinger

9

object named as

Jacob J Schlesinger

1 reference

19 September 2017

10

Aravinda de Silva

1 reference

19 September 2017

Zhihua Kou

1

1 reference

19 September 2017

Joanne Y H Lim

2

1 reference

19 September 2017

Matthew Quinn

4

1 reference

19 September 2017

Huiyuan Chen

5

1 reference

19 September 2017

Shengyong Liu

6

1 reference

19 September 2017

Luis Martinez-Sobrido

7

1 reference

19 September 2017

Xia Jin

12

1 reference

19 September 2017

language of work or name

English

0 references

publication date

4 December 2010

1 reference

19 September 2017

1 reference

19 September 2017

volume

410

1 reference

19 September 2017

issue

1

1 reference

19 September 2017

page(s)

240-247

1 reference

The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Primary Human Splenic Macrophages, but Not T or B Cells, Are the Principal Target Cells for Dengue Virus Infection In Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Role of dendritic cells in antibody-dependent enhancement of dengue virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

American Genotype Structures Decrease Dengue Virus Output from Human Monocytes and Dendritic Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Cross-reacting antibodies enhance dengue virus infection in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Cytokine gene expression and protein production in peripheral blood mononuclear cells of children with acute dengue virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Early Immune Activation in Acute Dengue Illness Is Related to Development of Plasma Leakage and Disease Severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

The Alexander D. Langmuir Lecture. The pathogenesis of dengue. Molecular epidemiology in infectious disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Pathogenesis of dengue: challenges to molecular biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Dengue vaccine development and dengue viral neutralization and enhancement assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

A role for IgG immune complexes during infection with the intracellular pathogen Leishmania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine Development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Elevated levels of IL-8 in dengue hemorrhagic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Differential Enhancement of Dengue Virus Immune Complex Infectivity Mediated by Signaling-Competent and Signaling-Incompetent Human Fc RIA (CD64) or Fc RIIA (CD32)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Innate and adaptive cellular immunity in flavivirus-naïve human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

Detection of Dengue Virus Replication in Peripheral Blood Mononuclear Cells from Dengue Virus Type 2-Infected Patients by a Reverse Transcription-Real-Time PCR Assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.11.007

10.1016/J.VIROL.2010.11.007

7 January 2021

Identifiers

DOI

1 reference

19 September 2017

1 reference